Siddappa N. Byrareddy
Siddappa N. Byrareddy
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
HA Rothan, SN Byrareddy
Journal of autoimmunity 109, 102433, 2020
Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase …
K Balasubramanyam, RA Varier, M Altaf, V Swaminathan, NB Siddappa, ...
Journal of Biological Chemistry 279 (49), 51163-51171, 2004
The 2022 outbreak and the pathobiology of the monkeypox virus
N Kumar, A Acharya, HE Gendelman, SN Byrareddy
Journal of autoimmunity 131, 102855, 2022
Impact of social determinants of health on the emerging COVID-19 pandemic in the United States
S Singu, A Acharya, K Challagundla, SN Byrareddy
Frontiers in public health 8, 564623, 2020
Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses
SR Kannan, AN Spratt, AR Cohen, SH Naqvi, HS Chand, TP Quinn, ...
Journal of autoimmunity 124, 102715, 2021
Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy
SN Byrareddy, J Arthos, C Cicala, F Villinger, KT Ortiz, D Little, N Sidell, ...
Science 354 (6309), 197-202, 2016
Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies
SR Kannan, AN Spratt, K Sharma, HS Chand, SN Byrareddy, K Singh
Journal of autoimmunity 126, 102779, 2022
Specific inhibition of p300-HAT alters global gene expression and represses HIV replication
K Mantelingu, BAA Reddy, V Swaminathan, AH Kishore, NB Siddappa, ...
Chemistry & biology 14 (6), 645-657, 2007
Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine
U Ranga, R Shankarappa, NB Siddappa, L Ramakrishna, R Nagendran, ...
Journal of virology 78 (5), 2586-2590, 2004
Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy–treated macaques
PJ Santangelo, KA Rogers, C Zurla, EL Blanchard, S Gumber, K Strait, ...
Nature methods 12 (5), 427-432, 2015
Clade‐specific differences in neurotoxicity of human immunodeficiency virus‐1 B and C Tat of human neurons: significance of dicysteine C30C31 motif
M Mishra, S Vetrivel, NB Siddappa, U Ranga, P Seth
Annals of neurology 63 (3), 366-376, 2008
Targeting α4β7 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection
SN Byrareddy, B Kallam, J Arthos, C Cicala, F Nawaz, J Hiatt, EN Kersh, ...
Nature medicine 20 (12), 1397-1400, 2014
The journey of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) from lab to clinic
V Namasivayam, M Vanangamudi, VG Kramer, S Kurup, P Zhan, X Liu, ...
Journal of medicinal chemistry 62 (10), 4851-4883, 2018
Anti-HIV IgA isotypes: differential virion capture and inhibition of transcytosis are linked to prevention of mucosal R5 SHIV transmission
JD Watkins, AM Sholukh, MM Mukhtar, NB Siddappa, SK Lakhashe, ...
Aids 27 (9), F13-F20, 2013
HIV-1 clade-specific differences in the induction of neuropathogenesis
VR Rao, AR Sas, EA Eugenin, NB Siddappa, H Bimonte-Nelson, ...
Journal of neuroscience 28 (40), 10010-10016, 2008
Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaques
L Micci, ES Ryan, R Fromentin, SE Bosinger, JL Harper, T He, S Paganini, ...
The Journal of clinical investigation 125 (12), 4497-4513, 2015
Mental health issues during and after COVID-19 vaccine era
K Pandey, M Thurman, SD Johnson, A Acharya, M Johnston, EA Klug, ...
Brain research bulletin 176, 161-173, 2021
An anti-HIV-1 V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIV
JD Watkins, NB Siddappa, SK Lakhashe, M Humbert, A Sholukh, ...
PloS one 6 (3), e18207, 2011
SARS-CoV-2 infection leads to neurological dysfunction
A Acharya, BD Kevadiya, HE Gendelman, SN Byrareddy
Journal of Neuroimmune Pharmacology 15, 167-173, 2020
COVID-19 and cancer comorbidity: therapeutic opportunities and challenges
AS Pathania, P Prathipati, BAA Abdul, S Chava, SS Katta, SC Gupta, ...
Theranostics 11 (2), 731, 2021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20